1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Conformis Inc.

Conformis is a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, which Conformis refers to as personalized, individualized, or sometimes as customized, to fit each patient's unique anatomy. Conformis offers a broad line of sterile, personalized knee and hip implants and single-use instruments delivered to hospitals and ambulatory surgical centers. In clinical studies, the Conformis iTotal® CR knee replacement system demonstrated superior clinical outcomes, including better function and greater patient satisfaction, compared to traditional, off-the-shelf implants. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.


Conformis, Inc. (CFMS) Q4 2022 Earnings Call Transcript
Mar 02, 2023 02:49am

Conformis, Inc. (NASDAQ:NASDAQ:CFMS) Q4 2022 Results Conference Call March 1, 2023 4:30 PM ETCompany ParticipantsMark Augusti - President and Chief Executive OfficerBob Howe - CFO and…

Source:Seeking Alpha
ConforMIS GAAP EPS of -$0.51, revenue of $17.4M
Mar 01, 2023 21:37pm

ConforMIS press release (CFMS): Q4 GAAP EPS of -$0.51.Revenue of $17.4M (+13% Y/Y).Product revenue of $14.2 million, a decrease of 7% year-over-year on a reported basis and 6% on…

Source:Seeking Alpha
ConforMIS: Q4 Earnings Snapshot
Mar 01, 2023 21:32pm

BILLERICA, Mass. (AP) — BILLERICA, Mass. (AP) — ConforMIS Inc. (CFMS) on Wednesday reported a loss of $3.7 million in…

Conformis, Inc. Reports Fourth Quarter and Year End 2022 Financial Results
Mar 01, 2023 21:05pm

BILLERICA, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the fourth quarter and year ended December 31, 2022.

ConforMIS Q4 2022 Earnings Preview
Feb 28, 2023 22:35pm

No summary available.

Source:Seeking Alpha
Conformis, Inc. to Participate in Upcoming Investor Conferences
Feb 21, 2023 21:15pm

BILLERICA, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will participate at two upcoming investor conferences.

A stock that deserves closer examination: Conformis Inc. (CFMS)
Feb 20, 2023 16:24pm

A share of Conformis Inc. (NASDAQ:CFMS) closed at $1.74 per share on Friday, down from $1.75 day before. While Conformis Inc. has underperformed by -0.57%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CFMS fell by -89.53%, with highs and lows ranging from $18.77 to $1.20, […]

Source:US Post News
Conformis settles patent dispute with Bodycad (NASDAQ:CFMS)
Feb 15, 2023 22:42pm

Conformis (CFMS) said Wednesday that it entered into a settlement and license agreement with Bodycad Laboratories and Bodycad USA, resolving the patent infringement dispute.

Source:Seeking Alpha
Conformis Q4 preliminary revenue above estimates (NASDAQ:CFMS)
Feb 10, 2023 18:13pm

Conformis (CFMS) announces preliminary fourth quarter total revenue of about $17.4M vs $13.67M consensus. Product revenue of about $14.2M, down 7% year-over-year on a reported basis…

Source:Seeking Alpha